Clinical Scorecard: Case Study and Literature Analysis of Multidrug-Resistant Tuberculosis Affecting Breast and Uterine Adnexa

At a Glance

Key Highlights

• MDR-TB cases are increasing globally, with significant prevalence in China.
• Extrapulmonary tuberculosis accounts for 15-20% of cases, often misdiagnosed.
• Breast and female genital tuberculosis are rare and may mimic other conditions.
• Early microbiological testing is crucial for accurate diagnosis and treatment.
• The case highlights the importance of recognizing atypical presentations of TB.

Guideline-Based Recommendations

Diagnosis

• Utilize microbiological and drug susceptibility testing for accurate diagnosis.
• Consider TB in differential diagnosis for breast and adnexal lesions.

Management

• Initiate appropriate anti-tuberculosis therapy upon diagnosis of MDR-TB.
• Monitor for treatment response and potential complications.

Monitoring & Follow-up

• Regular follow-up with imaging and laboratory tests to assess treatment efficacy.
• Monitor for adverse effects of anti-tuberculosis medications.

Risks

• Delayed diagnosis can lead to disease progression and complications.
• Increased risk of transmission in cases of untreated MDR-TB.

Patient & Prescribing Data

Women with MDR-TB affecting breast and adnexal regions.

Combination therapy is essential for managing MDR-TB effectively.

Clinical Best Practices

• Encourage early referral for suspected cases of MDR-TB.
• Implement routine screening for TB in high-risk populations.

References

• Global Tuberculosis Report 2024
• Literature on Extrapulmonary Tuberculosis